CSOP Hang Seng Biotech ETF (03174.HK) Falls 1.11%, Latest Price at HKD 2.848
NewTimeSpace News: As of 15:46 on June 11, according to the latest data from the Hong Kong Stock Exchange, CSOP Hang Seng Biotech ETF (03174.HK) declined 1.11%, with the latest price at HKD 2.848. The ETF recorded a volume of 5.9845 million shares, a turnover of HKD 16.9505 million, a turnover rate of 2.36%, an average price of HKD 2.876, a latest Net Asset Value (NAV) of HKD 2.889, a discount rate of 0.30%, and total Assets Under Management (AUM) of approximately HKD 733 million.
CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Hong Kong Listed Biotech Index, the authoritative benchmark specifically measuring the overall performance of biotechnology companies listed in Hong Kong. Its constituents are primarily selected from leading enterprises in innovative drugs, biotechnology, medical devices, and life sciences listed under Chapter 18A of the Listing Rules.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- LINK TOUCH: Closes RMB 100M-Level D3 Round With 14 Investors
- CSOP Hang Seng Biotech ETF (03174.HK) Up 4.32% as FDA Grants Priority Review to BeiGene Combo
- CSOP HS Biotech(03174.HK) +2.81%, Hengrui 9M net profit up 20.38%
- Chinese Innovative Drugs Set Record Share of ESMO Late-Breaking Abstracts; CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.81% Intraday
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.55% Intraday as Record 29 Chinese Studies Make ESMO Late-Breaker List